These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 33426736)

  • 1. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells.
    Yokota Y; Noda T; Okumura Y; Kobayashi S; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Murakami T; Umeshita K; Doki Y; Eguchi H
    Cancer Sci; 2021 Mar; 112(3):1275-1288. PubMed ID: 33426736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins.
    Fang JH; Zhang ZJ; Shang LR; Luo YW; Lin YF; Yuan Y; Zhuang SM
    Hepatology; 2018 Oct; 68(4):1459-1475. PubMed ID: 29637568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 6. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
    Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
    J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.
    Di Modica M; Regondi V; Sandri M; Iorio MV; Zanetti A; Tagliabue E; Casalini P; Triulzi T
    Cancer Lett; 2017 Jan; 384():94-100. PubMed ID: 27693459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
    J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
    Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
    RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-transmitted long non-coding RNA
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.
    Zhao S; Li J; Zhang G; Wang Q; Wu C; Zhang Q; Wang H; Sun P; Xiang R; Yang S
    Cell Physiol Biochem; 2019; 53(1):19-35. PubMed ID: 31162914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.